Innovative funding partner throughout the growth life-cycle

Latest developments

News, Portfolio 30/05/2023              

Sylq selects ThetaRay AI to automate AML transaction monitoring and customer screening

Sylq, the French e-payments leader, and ThetaRay, a leading provider of AI-powered transaction monitoring technology, today announced a new collaboration to implement high-performance AI transaction monitoring and automated customer screening to…
News, Portfolio 24/05/2023              

HiBob’s CPO Nirit Peled Muntz Recognized as a Top Leader in Diversity, Equity, and Inclusion by Mogul

HiBob, the company behind Bob, the modern HR platform that powers productivity, engagement and retention, today is proud to announce its Chief People Officer, Nirit Peled Muntz has been named to Mogul’s…
News, Portfolio 22/05/2023              

Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases

Ironwood Pharmaceuticals, Inc. (“Ironwood”) (Nasdaq: IRWD), a GI-focused healthcare company, and VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel, transformational treatments for severe rare gastrointestinal conditions,…

Subscribe to our mailing list

Get our newsletter, Kreos updates and information on our events right to your mailbox.

Market Leading Growth Debt Investor for +25 years

Kreos Capital provides innovative and flexible debt solutions to equity-backed, pan-European and Israeli high-growth companies in the technology and healthcare sectors.

For over 25 years, our sole focus has been to support our ambitious ecosystem with personal, adaptable and responsive financing through every stage of the growth life cycle – from entry level through to late-stage growth including pre and post-IPO.